BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023

November 6, 2023

POMPANO BEACH, FL / November 6, 2023 / BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today that it plans to release its third quarter 2023 financial results pre-market on Tuesday, November 14, 2023.

BioStem will host a conference call and webcast at 10:30am ET on Tuesday, November 14, 2023. The call will include a discussion of third quarter 2023 financial results and a corporate update.

The live call can be accessed by dialing 1-877-317-6789 (domestic) or 1-412-317-6789 (international).

The live and archived webcast of the call will also be available on the BioStem Technologies website under the Investors section or by following this link:

Subscribe To Our Newsletter

To stay up to date on all of our news, products, and achievements, please subscribe to our newsletter

Contact Information
(954) 380-8342

2836 Center Port Circle
Pompano Beach, FL 33064




© 2021 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.
For screen reader problems with this website, please call (954) 380-8342 for assistance.